<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Angelis Consulting Group | Rice | Activity</title>
	<link>https://angelisconsulting.com/members/answerjuice9/activity/</link>
	<atom:link href="https://angelisconsulting.com/members/answerjuice9/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Rice.</description>
	<lastBuildDate>Thu, 17 Sep 2026 02:02:40 -0500</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">0fc5b6c30be3983b45d32a690ffa403c</guid>
				<title>Rice posted an update: Multiple Myeloma Class Action Lawsuits: What Patients Need to [&#133;]</title>
				<link>https://angelisconsulting.com/activity/p/27336/</link>
				<pubDate>Wed, 12 Aug 2026 04:39:03 -0500</pubDate>

									<content:encoded><![CDATA[<p><strong>Multiple Myeloma Class Action Lawsuits: What Patients Need to Know</strong> </p>
<p><em>By a health‑law writer</em> </p>
<p>Intro</p>
<p>Multiple myeloma (MM) is a fairly unusual but aggressive blood cancer that affects plasma cells in the bone marrow. Over the previous years, a growing number of clients and their families have actually turned to the courts, filing c&hellip;<span class="activity-read-more" id="activity-read-more-27336"><a href="https://angelisconsulting.com/activity/p/27336/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">457fe5ca3fe9fb1875c415a95faca523</guid>
				<title>Rice posted an update: Multiple Myeloma Class Action Lawsuit: What Patients Need to [&#133;]</title>
				<link>https://angelisconsulting.com/activity/p/27295/</link>
				<pubDate>Wed, 12 Aug 2026 04:32:49 -0500</pubDate>

									<content:encoded><![CDATA[<p><strong>Multiple Myeloma Class Action Lawsuit: What Patients Need to Know</strong> </p>
<p><em>An informative guide for anybody impacted by multiple myeloma who is thinking about&#8211; or simply curious about&#8211; joining a class‑action lawsuit.</em> </p>
<p>Intro</p>
<p>Multiple myeloma (MM) is a plasma‑cell malignancy that affects approximately 34,000 new clients each year in the Uni&hellip;<span class="activity-read-more" id="activity-read-more-27295"><a href="https://angelisconsulting.com/activity/p/27295/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d214e18555f064ceba0cf88d08ecebd3</guid>
				<title>Rice posted an update: Multiple Myeloma Class Action Lawsuits: What Patients Need to [&#133;]</title>
				<link>https://angelisconsulting.com/activity/p/27109/</link>
				<pubDate>Wed, 12 Aug 2026 03:41:23 -0500</pubDate>

									<content:encoded><![CDATA[<p><strong>Multiple Myeloma Class Action Lawsuits: What Patients Need to Know</strong> </p>
<p><em>By a health‑law author</em> </p>
<p>Introduction</p>
<p>Multiple myeloma (MM) is a relatively rare however aggressive blood cancer that affects plasma cells in the bone marrow. Over the previous decade, a growing variety of patients and their families have turned to the courts, filing c&hellip;<span class="activity-read-more" id="activity-read-more-27109"><a href="https://angelisconsulting.com/activity/p/27109/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">bf68c71c6ca39230fb7f2d68bba3b937</guid>
				<title>Rice became a registered member</title>
				<link>https://angelisconsulting.com/activity/p/27093/</link>
				<pubDate>Wed, 12 Aug 2026 03:34:32 -0500</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>